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A B S T R A C T 
 
 
Introduction: The geography and logistics of living in remote Australia provide unique challenges in providing dedicated primary 
healthcare services to tackle the rising incidence of skin cancer. The aim of this study was to ascertain whether the Royal Flying 
Doctor Service (RFDS) skin cancer clinic could improve skin cancer health outcomes for the target population while providing 
care at a level consistent with that documented for metropolitan skin cancer clinics. 
Methods: This retrospective longitudinal report compared historical controls with a dedicated fly-in/fly-out primary care skin 
cancer outreach clinic provided by the RFDS. The clinic was run concurrently with the regular primary care medical service; the 
entire focus of this additional service was on skin cancer diagnosis and management. This model was used to minimise the 
additional costs of providing the service. 
Results: During the study period a total of 316 people were seen at this skin cancer clinic (29% of the total non-Indigenous 
population) with 39% of those aged over 50 years seen. There was an average of 1.1 consultations per person (343 consultations in 
total), with a procedure performed in approximately one-third of consultations. The demographic most likely to have a lesion 
removed were over 50 year-old males (p<0.0001). The rate of skin cancer detection was 15/1000 adults/year. The number of 
lesions removed per year increased from 37 to 42 after the intervention, with no statistically significant change in the percentage of 
excised lesions that were malignant (44%). For over 50 year-old males there was a statistically significant increase in the 
proportion of excised lesions that were melanomas (χ2 = 6.015; p = 0.013). This corresponded to a four-fold rise in melanoma 
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detection from 0.2/1000 people/year pre-intervention to 2/1000 people/year post-intervention. A comparison of the skin clinic’s 
effectiveness with documented results from other Australian non-specialist skin cancer services demonstrated a low number needed 
to treat for melanoma which is consistent with high diagnostic accuracy. This is also supported by a relatively high consultation to 
biopsy ratio. The biopsy treatment ratio and percentage of lesions that were malignant were similar to those seen in other 
Australian settings. 
Conclusion: The RFDS skin cancer clinic outcomes were not dissimilar to those seen in metropolitan skin cancer clinics. The 
small population and consequently low statistical power mitigated against certainty in concluding that clinical outcomes were 
enhanced. Further studies would assist in the future development of models for skin cancer clinics in remote areas.  
 
Key words: primary care, remote, skin cancer, skin cancer clinic. 
 
 
 
Introduction 
 
Skin cancer, both of the melanoma and non-melanoma skin 
cancer (NMSC) types are now the most common types of 
cancer in white populations across the globe1. In 2001, 
NMSC was both the most common cancer in Australia and 
the most expensive to treat2. Queensland, Australia, has the 
highest incidence of melanoma in the world3. Although the 
rate in younger Queenslanders is stabilising due to extensive 
health promotion programs, melanoma incidence in older 
people continues to rise rapidly across both metropolitan and 
rural locations4. As the key risk factor for melanoma and 
NMSC is ultraviolet sun exposure, those living and working 
in remote parts of Queensland, where outdoor work and 
leisure activities are common, are at increased risk compared 
with their metropolitan counterparts1. 
 
Traditionally skin cancers in Australia of both the melanoma 
and NMSC types were managed by primary care doctors in 
general practice, supported by specialist services where 
appropriate5. With the dramatic rise in both the incidence 
and public awareness of skin cancer, there has been a 
concomitant rise in the development within the primary care 
health sector of dedicated skin cancer clinics. This is 
reflected in the rising proportion of all cause skin cancers 
managed by GPs who excise the majority of skin cancers6.  
 
Remote medical practice is increasingly considered to have a 
different scope of practice and logistical structure from rural 
or metropolitan heath care services7. Apart from the lower 
number of practitioners per capita and issues of distance and 
isolation, remote primary care medical practice often 
requires novel funding arrangements to ensure viability. This 
requires consideration of population density below financial 
viability for generalist medical staff working full time in the 
community.  
 
Health care services to the remote parts of the state of 
Queensland, Australia are primarily provided by Queensland 
Health, a state government agency and the Royal Flying 
Doctor Service of Australia (RFDS) Queensland Section, a 
not for profit non-government organisation. The RFDS has 
been providing healthcare services including aeromedical 
retrieval, telemedicine, telepharmacy and face-to-face 
primary care to people living in remote Queensland for more 
than 80 years. Over the last decade, there has been 
coordinated role delineation within face-to-face primary care 
service delivery across sites between these two 
organisations. In most instances, QH provides the resident 
nursing and ancillary staff and their appropriately equipped 
physical infrastructure, although in some locations the 
buildings are provided by local government. The RFDS 
provides a range of visiting health care staff including 
medical, nursing, mental health and allied health 
professionals. The primary care doctors in the communities 
considered in this study are RFDS staff members who visit 
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each community on a regular, scheduled fly-in/fly-out basis 
for face-to-face clinics. Further particulars about the services 
provided by the RFDS are detailed elsewhere8,9.  
 
The RFDS primary care medical services to remote locations 
are conducted in a traditional Australian general practice 
structure: a mixture of booked and walk-in patients present 
with a myriad of unselected problems to the doctor working 
in an office-based practice environment. All clinical services 
and pathology are provided free of charge to the patient, 
although in most locations regular and some acute 
medications must be paid for by the patient. The RFDS 
medical services have always included provision for the 
screening, diagnosis and management of skin cancers as this 
is an intrinsic component of Australian general practice10. 
However, in light of the well documented shortage of 
medical staff in remote areas, the amount of time available 
per patient for skin cancer management has to be balanced 
against other competing medical problems.  
 
In recent years RFDS medical staff and management 
considered how best to increase service levels for skin 
cancer considering the limitations to medical staff time while 
at face-to-face clinics, the known higher rate of skin cancers 
in remote areas, increasing recognition of the benefits of 
prioritising screening for skin cancer, and the development 
in metropolitan areas of dedicated primary care skin cancer 
services. Key considerations were ensuring additional 
medical staff time was focussed on skin cancer care and that 
service delivery costs were minimised. The skin cancer 
clinic model chosen by RFDS was the addition of a second 
doctor with special expertise in skin cancer care to 
accompany the primary care doctor on regular scheduled 
visits where face-to-face primary care clinics were 
conducted. The key benefit envisaged from the addition of 
the skin cancer clinic was that the skin cancer care doctor 
could focus their entire attention on this area and direct any 
other intercurrent issues to the regular primary care doctor 
who was present in the adjacent office. The service would 
also allow for staff to develop their special interest in skin 
cancer work and consequently further develop skills in this 
area. Another important benefit of this model was that 
additional costs were essentially limited to the salary of the 
additional doctor and costs generated through treatment (eg 
equipment for skin excisions, histology, and referral where 
necessary). This was achieved through the additional doctor 
utilising existing air transport (whose costs were per aircraft, 
not per seat) and nursing or administrative staff already 
present in the clinics for the primary care clinic. 
 
The aim of this study was to ascertain whether the RFDS 
skin cancer clinic could improve the skin cancer health 
outcomes for the target population while providing care at a 
level consistent with that documented for metropolitan skin 
cancer clinics. 
 
Methods 
 
The study was a retrospective longitudinal report. The 
intervention period was from 1 April 2006 to 30 June 2008, 
with the historical control period from 1 April 2001 to 31 
March 2006. 
 
Data sources 
 
All data used in this study were obtained in a de-identified 
format from the RFDS databases and internal audit data that 
are regularly collected for internal and government 
reporting. Therefore there were no specific ethical 
requirements beyond institutional approval. 
 
Population 
 
The population under study was adult, non-Indigenous 
residents living and working in six distinct communities 
within one remote region in outback Queensland, Australia. 
The six communities all have employment and leisure 
options predominantly in outdoor activities with 
consequently significant long-term sun exposure. The 2006 
census identified 1004 non-Indigenous adults aged over  
18 years living in the region under study11. The RFDS 
medical staff provided a one day face-to-face primary care 
clinic on a fly-in/fly-out basis at each of the six study 
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locations every 1 to 2 weeks. Each clinic provided 
approximately 6 hours of clinical time for the doctor to see 
the patients. There were no other doctors providing 
scheduled medical care to these communities.  
 
Program 
 
The RFDS skin clinic was supplied with standard equipment 
and a dermatoscope. A Siascope (Astron Clinica Pty 
Limited; Brisbane, QLD, Australia) which performed 
spectrophotometric intra-cutaneous analysis was donated to 
(rather than requested for) the RFDS clinic, and played a 
minor, peripheral role as appropriate for this form of 
technology in this context12. 
 
The medical staff attending the RFDS primary care skin 
cancer clinic was shared over the study time between  
6 different people. Ideally one or two staff would provide the 
entire service to ensure continuity of care but the realities of 
salaried staff taking study, sick or vacation leave, plus the 
natural cycle of staff turnover made this impossible. 
Nevertheless each staff member attending the skin cancer 
clinic had a special expertise in the service and received 
training in use of the Siascope.  
 
The local resources regularly utilised in these six isolated 
communities were harnessed to advertise the service, 
including public noticeboards, community newspapers and 
word of mouth. The population were advised that the clinic 
would provide a diagnostic and treatment service for skin 
cancer, including comprehensive checking of an individual’s 
skin for the presence of skin cancer. 
 
Definitions 
 
There are a number of different ways that outcomes are 
measured in relation to primary care skin cancer services. 
Recent Australian studies have developed three key 
indicators that have been used to objectively assess the 
quality of the service in standard general practice settings as 
well as dedicated primary care skin cancer clinics13,14. The 
consultation to biopsy ratio (CBR) equals the total number of 
consultations divided by total number of biopsies. Biopsy to 
treatment ratio (BTR) equals the total number of biopsies 
divided by total number of non-melanoma skin cancers 
(treated either surgically or non-surgically). Number needed 
to treat (NNT) equals the number of benign lesions 
(pigmented or non-pigmented) excised per melanoma, 
defined as number of benign lesions excised plus number of 
melanomas excised divided by number of melanomas 
excised. 
 
Analysis methodology 
 
Simple frequency analysis was performed using the 
Statistical Package for Social Sciences v 16 (SPSS Inc; 
Chicago, Il, USA). Categorical data were analysed using χ2 
analysis. Continuous variables were analysed by analysis of 
variance. Statistical significance was defined as p<0.05.  
 
Institutional review board approval 
 
This study of de-identified data was approved by the Human 
Research Ethics Committees of both the University of 
Queensland and James Cook University. 
 
Results 
 
During the study period a total of 316 people were seen at 
the RFDS primary care skin cancer clinic (29% of the total 
non-Indigenous population) with 39% of those aged over  
50 years seen. The male : female ratio was 1:0.9 and the 
average age was 48.5 +/- 16.7 years. The demographics of 
the population who attended this service clinic are detailed 
(Table 1). 
 
There was an average of 1.1 consultations per person  
(343 consultations in total), with a procedure performed in 
approximately one-third of consultations. Details of clinical 
processes are listed (Table 2). The demographic most likely 
to have a lesion removed were over 50 year-old males 
(p<0.0001). 
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Table 1: Age profile of the skin clinic population; source: 2006 census data for non-Indigenous adults11 
 
Age range Male Female Total 
 Clin Cens Clin as % 
of cens 
Clin Cens Clin as % 
of cens 
Clin Cens Clin as % 
of cens 
18–49 years  73 294 24 90 242 38 163 536 30 
50+ years  103 272 38 80 196 41 183 468 39 
Total 156 566 28 137 438 31 293 1004 29 
                    Cens, Census; clin, clinic. 
 
 
 
 
Table 2: Clinical processes at the skin clinic 
 
Male Female Clinical process 
18–50 years 50+ years 18–50 years 50+ years 
Total 
Examination only 41 50 62 41 194 
Cryotherapy only 19 22 6 25 72 
Removal of lesion† 6 18 7 2 33 
Siascopy only 2 4 1 1 8 
Referral to plastic surgeon for excision/ biopsy 2 2 1 1 6 
Total 70 95 78 70 313 
            †One or more lesions. 
 
 
 
 
 
 
The histological findings by rate per year and absolute 
numbers of excised lesions are detailed (Table 3). This 
includes those lesions excised by the plastic surgeon after 
referral from the RFDS primary care skin clinic doctor who 
felt that the technical requirements of the excision were 
beyond the scope of the RFDS service. The rate of skin 
cancer detection was 15/1000 adults/year. The number of 
lesions removed/year increased from 37 to 42 after the 
intervention, with no statistically significant change in the 
percentage of excised lesions that were malignant (44%). 
The average age at removal of benign lesions was 52.1 +/- 
16 years was statistically significantly younger than for 
malignant/pre-malignant lesions at 59.3 +/- 11.1 years (t = -
4.333, p<0.0001). For over 50 year-old males, there was a 
statistically significant increase in the proportion of excised 
lesions that were melanomas (χ2 = 6.015; p = 0.013). This 
corresponded to a four-fold rise in melanoma detection from 
0.2 /1000 people/year pre-intervention (a total of three in the 
5 years before the clinic) to 2 /1000 people/year post-
intervention (four in the 2 years of the skin cancer clinic’s 
operation). There were no other statistically significant 
findings pre- and post-intervention across age and sex 
demographics. 
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Table 3: Histology results, pre- versus post-intervention 
 
Male Female Total 
18-50 years 50+ years 18-50 years 50+ years  
pre post pre post pre post pre post pre post 
Histology 
n/y t/n n/y t/n n/y t/n n/y t/n n/y t/n n/y t/n n/y t/n n/y t/n n/y t/n n/y t/n 
SCC 1.2 6 0 0 6.2 31 4.5 9 0.4 2 0 0 0.4 2 2 4 8.2 41 6.5 13 
BCC 1 5 0.5 1 6.8 34 4.5 9 0 0 0 0 0.2 1 0.5 1 8 40 5.5 11 
Melanoma 0 0 0 0 0.2 1 2 4 0.2 1 0 0 0.2 1 0 0 0.6 3 2 4 
Pre-
malignant 
0 0 0 0 0.2 1 0 0 0.2 1 0.5 1 0.4 2 0.5 1 0.8 4 1 2 
Benign 5.8 29 4 8 7 35 11.5 23 2.8 14 5 10 3.8 19 6.5 13 19.4 97 27 54 
Total 8 40 4.5 9 20.4 102 22.5 45 3.6 18 5.5 11 5 25 9.5 19 37 185 42 84 
BCC, Basal cell carcinoma; n/y, number per year; SCC, squamous cell carcinoma; t/n, total per year. 
†Includes lesions excised/ biopsied after referral to the plastic surgeon specifically for this purpose (ie not for diagnosis). 
 
 
 
Discussion 
 
A comparison of the skin clinics’ effectiveness compared 
with documented results from other Australian non-specialist 
skin cancer services is detailed (Table 4). There was a low 
number needed to treat for melanoma which is consistent 
with high diagnostic accuracy. This is also supported by a 
relatively high consultation to biopsy ratio. The biopsy 
treatment ratio and percentage of lesions that were malignant 
were similar to those seen in other Australian settings, 
suggesting that NMSC management was of a similar 
standard to those settings. In light of the trend for doctors 
working in metropolitan skin cancer clinics being required to 
have formal certification in skin cancer care, this is very 
reassuring. Although RFDS medical staff who work within 
the skin cancer clinic have a specific interest in this area, 
they are also clinically active in a variety of other clinical 
areas, including procedural areas such as aeromedical 
retrieval, and consequently have a considerable continuing 
medical education (CME) burden. Due to the difficulties 
experienced in sourcing all medical staff for remote 
Australia, the imposition of a formal requirement for specific 
training, certification and CME in skin cancer care would 
make it even more difficult to source medical staff for this 
clinic. A second benefit of the RFDS results being similar to 
metropolitan skin cancer clinics is that the patients who are 
the consumers of this clinical product can be reassured that 
their care is not being compromised by their geographical 
location. 
 
This study suggests an improved detection rate for 
melanoma although clinical relevance is compromised by the 
low numbers of patients and limited power of the study. 
Nevertheless, the suggestion of improved melanoma 
detection rates if confirmed by ongoing analysis of clinic 
results, would be of considerable import as people in remote 
areas have a higher rate of melanoma yet poorer health 
outcomes for melanoma15. 
 
This study found that older males had the highest rate of 
melanoma, consistent with other studies16,17. This is not 
entirely surprising because the environment in which this 
study was conducted consists of outdoor work and leisure 
activities where consequent high sun exposure is the norm. 
Traditionally men would have been exposed to the sun for 
longer periods than women, and older males would have had 
significant ultraviolet exposure before the advent of modern 
sun protection advice. 
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Table 4: Comparison with published data on Australian non-specialist dermatology services 
 
RFDS Program results 
Pre- 
intervention 
Post- 
intervention 
Australia 2005-
2006† 
QuIP¶ Skin clinic 
A§ 
Skin clinic 
B†† 
CBR N/A 3.7 N/A N/A 1.8 N/A 
BTR 2.2 3.2 1.0 0.7 3.1 0.5 
NNT 33.3 14.5 25.0 39.0 28.8 24.0 
Excised lesions +ve 
for skin cancer (%) 
47.6 35.7 39.0 53.9 59.9 46.4 
BTR, Biopsy to treatment ratio; CBR, consultation to biopsy ratio; N/A, not available; NNT, number needed to treat; QuIP,  
Queensland Innovative Practices; RFDS, Royal Flying Doctor Service.  
†Based on Medicare Australia data[14]. 
¶Queensland Innovative Practices group comprising three (one metropolitan, one provincial city and one rural) non-specialised general  
practices interested in researching clinical general practice[14]. 
§Primary care skin cancer clinic network, consisting of seven clinics and staffed by 20 doctors, located in the Northern Territory,  
Queensland and New South Wales[13]. 
††Primary care skin cancer clinic network, consisting of four clinics in Queensland (14) 
 
 
The RFDS skin cancer clinic appeared to result in an 
increase in the detection rate of melanoma, a finding that 
will need to be confirmed by larger studies. However, it may 
be related to the increase in attendance by older males to this 
new clinical service. All new services undergo an 
accelerated period of interest when they begin and this may 
have accounted for a significant number of people coming to 
the skin clinic who were not seen previously. However, the 
service was provided over more than 2 years which would 
suggest this cause would have been mitigated. The other 
potential attraction to people who did not regularly attend 
health services was that this was advertised to the 
community as a dedicated skin cancer clinic. The advertising 
and positioning of the service may have duplicated the 
phenomenon that appears to make metropolitan dedicated 
primary care skin cancer clinics attractive to a segment of the 
population who may be otherwise reluctant to attend health 
services. This may be particularly relevant to older males 
who are known to be less likely to present for health care18.  
 
Another possible reason for the apparent improved detection 
rate of melanoma is a change in the clinical acumen of the 
medical staff. This is consistent with the observed fall in the 
number needed to treat for melanoma diagnosis. This is low 
when compared with other contemporary Australian settings, 
and is also consistent with the high consultation to biopsy 
ratio, suggesting the medical staff felt confident in their 
clinical diagnostic acumen. These findings may be due to a 
change in medical staff skill, increased time per patient in 
the context of a skin cancer clinic when compared with a 
general clinic, or the addition of the diagnostic technology 
provided by the Siascope. The higher diagnostic acumen was 
not seen in NMSC where the biopsy to treatment ratio and 
the percentage of lesions that were benign were similar to 
other contemporary Australian settings19,20. These findings 
suggest that there was either differential enhancement of 
melanoma diagnosis or that the Siascope provided a distinct 
diagnostic input to the clinical process. Further studies 
would be required to define the relative importance of each 
of these distinct factors. 
 
Limitations 
 
A key limitation of this study was the use of historical 
controls. However, the geographical, demographic and 
service delivery nature of remote Queensland resulted in the 
absence of an appropriate formal control location. An 
important second issue was being unable to distinguish 
between the impact of advertising the new service and the 
consequent increase in interest and awareness about skin 
cancer and the actual delivery of skin cancer services within 
the clinic. However, advertising alone in the absence of an 
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expansion of services would have simply increased pressure 
on the already busy primary care medical service. 
Consequently, there would have been little scope for 
expanding services to meet increased demand (eg increasing 
clinical skin cancer screening). Additionally, the timeframe 
over which the study was conducted suggested the ongoing 
success of the program, rather than an increase in visitation 
at onset, that would be expected with advertising a new 
service. A third issue is whether simply increasing resources 
would have resulted in an improvement. It would appear 
self-evident that this was so until one considers the rather 
unusual logistics and geography of remote parts of 
Queensland. The number of hours of face-to-face medical 
services is determined as much by aircraft logistics (flight 
times, aircraft loads) and prevailing weather (affecting both 
flight movements and ground transport for those living out 
of town to reach the clinic across roads subject to flooding 
etc), as by the availability of medical staff to provide 
services. The model reported in this article demonstrated a 
mechanism to enhance skin cancer services which minimised 
additional costs and the dilution of a new additional service 
through servicing other intercurrent clinical problems. 
 
Conclusion 
 
In conclusion, the RFDS skin cancer clinic outcomes were 
not dissimilar to outcomes seen in metropolitan skin cancer 
clinics, with a suggestion that clinical outcomes were 
enhanced. Further studies would assist in the further 
development of models for skin cancer clinics in remote 
areas.  
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